A detailed history of Capital International Sarl transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Capital International Sarl holds 54,189 shares of REGN stock, worth $39.6 Million. This represents 1.53% of its overall portfolio holdings.

Number of Shares
54,189
Previous 47,136 14.96%
Holding current value
$39.6 Million
Previous $49.5 Million 14.99%
% of portfolio
1.53%
Previous 1.58%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$1024.09 - $1201.76 $7.22 Million - $8.48 Million
7,053 Added 14.96%
54,189 $57 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $5.93 Million - $7.2 Million
6,718 Added 16.62%
47,136 $49.5 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $8.38 Million - $9.22 Million
9,279 Added 29.8%
40,418 $38.9 Million
Q4 2023

Feb 13, 2024

BUY
$775.18 - $881.7 $2.38 Million - $2.71 Million
3,071 Added 10.94%
31,139 $27.3 Million
Q3 2023

Nov 13, 2023

SELL
$692.45 - $844.37 $1.88 Million - $2.29 Million
-2,716 Reduced 8.82%
28,068 $23.1 Million
Q2 2023

Aug 11, 2023

BUY
$700.03 - $830.35 $2.2 Million - $2.61 Million
3,148 Added 11.39%
30,784 $22.1 Million
Q1 2023

May 15, 2023

BUY
$680.49 - $826.97 $2.02 Million - $2.46 Million
2,969 Added 12.04%
27,636 $22.7 Million
Q4 2022

Feb 14, 2023

BUY
$705.89 - $766.39 $1.99 Million - $2.16 Million
2,815 Added 12.88%
24,667 $17.8 Million
Q3 2022

Nov 14, 2022

BUY
$573.97 - $724.32 $1.27 Million - $1.61 Million
2,218 Added 11.3%
21,852 $15.1 Million
Q2 2022

Aug 15, 2022

BUY
$548.35 - $738.84 $877,908 - $1.18 Million
1,601 Added 8.88%
19,634 $11.6 Million
Q1 2022

May 16, 2022

BUY
$595.12 - $698.43 $3.46 Million - $4.06 Million
5,819 Added 47.64%
18,033 $12.6 Million
Q4 2021

Feb 14, 2022

BUY
$543.48 - $670.97 $5.3 Million - $6.54 Million
9,748 Added 395.3%
12,214 $7.71 Million
Q3 2021

Nov 15, 2021

SELL
$574.03 - $680.96 $78,642 - $93,291
-137 Reduced 5.26%
2,466 $1.49 Million
Q2 2021

Aug 16, 2021

SELL
$472.8 - $558.54 $2,364 - $2,792
-5 Reduced 0.19%
2,603 $1.45 Million
Q1 2021

May 14, 2021

BUY
$446.73 - $548.2 $23,676 - $29,054
53 Added 2.07%
2,608 $1.23 Million
Q4 2020

Feb 16, 2021

BUY
$478.3 - $607.98 $139,663 - $177,530
292 Added 12.9%
2,555 $1.23 Million
Q3 2020

Nov 16, 2020

BUY
$544.75 - $658.21 $57,743 - $69,770
106 Added 4.91%
2,263 $1.27 Million
Q2 2020

Aug 14, 2020

BUY
$493.32 - $643.92 $301,418 - $393,435
611 Added 39.52%
2,157 $1.35 Million
Q1 2020

May 15, 2020

BUY
$336.18 - $494.43 $519,734 - $764,388
1,546 New
1,546 $755,000

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $78.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Capital International Sarl Portfolio

Follow Capital International Sarl and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International Sarl, based on Form 13F filings with the SEC.

News

Stay updated on Capital International Sarl with notifications on news.